Innovation & geistiges Eigentum · 28.6.20231 Min. Lesezeit
Grant of Interim Extension of the Term of U.S. Patent No. 7,517,522; Recombinant ADAMTS13 (rADAMTS13), a Recombinant A Disintegrin and Metalloprotease With Thrombospondin Type-1 Motifs 13
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 7,517,522 ('522 patent).